|
|
 |
|
| | |
| | | | |
organism-gene
|
|
PR:P01019 |
angiotensinogen (human)
|
hAGT
|
"An angiotensinogen that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01019]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000046285 |
angiotensinogen, signal peptide removed form (human)
|
hAGT/SigPep-
|
"An angiotensinogen (human) that has had the signal peptide removed. UniProtKB:P01019, 25-476." [PRO:DNx, Reactome:R-HSA-1998759]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051442 |
angiotensinogen N-glycosylated 1 (human)
|
hAGT/NGlyco:1
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G00912UN." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051443 |
angiotensinogen N-glycosylated 2 (human)
|
hAGT/NGlyco:2
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G08293MJ." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051444 |
angiotensinogen N-glycosylated 3 (human)
|
hAGT/NGlyco:3
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G10486CT." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051445 |
angiotensinogen N-glycosylated 4 (human)
|
hAGT/NGlyco:4
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G27947YN." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051446 |
angiotensinogen N-glycosylated 5 (human)
|
hAGT/NGlyco:5
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G40926MX." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051447 |
angiotensinogen N-glycosylated 6 (human)
|
hAGT/NGlyco:6
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G59626AS." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051448 |
angiotensinogen O-glycosylated 1 (human)
|
hAGT/OGlyco:1
|
"An angiotensinogen (human) that has been O-glycosylated at the residue equivalent to Thr-440 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01019-1, Thr-440, MOD:00005~GNO:G43417UB." [GlyGen:P01019-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
